Delene Kang

Delene Kang is currently the Senior Portfolio Lead at ApotheCom, an Inizio Company, since 2019 and also serves as Portfolio Director at ApotheCom: A MEDiSTRAVA Company. Previously, Delene worked as a Scientific Advisor and Project Manager at Synergy Medical from 2015 to 2017. Delene’s earlier experience includes positions as a Production Editor at Future Science Group from 2010 to 2012 and an Editor at CGP from 2009 to 2010. Delene earned a 2.1 degree in Biochemistry from the University of Warwick, completing their studies in 2009.